PA32540 for the secondary prevention of cardiovascular disease in patients at risk for aspirin-associated gastric ulcers.

about

PA32540 for the secondary prevention of cardiovascular disease in patients at risk for aspirin-associated gastric ulcers.

Item

http://www.wikidata.org/entity/Q36551017

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

PA32540 for the secondary prev ...... rin-associated gastric ulcers.

@ast

PA32540 for the secondary prev ...... rin-associated gastric ulcers.

@en

type

Item

label

PA32540 for the secondary prev ...... rin-associated gastric ulcers.

@ast

PA32540 for the secondary prev ...... rin-associated gastric ulcers.

@en

prefLabel

PA32540 for the secondary prev ...... rin-associated gastric ulcers.

@ast

PA32540 for the secondary prev ...... rin-associated gastric ulcers.

@en

P1476

PA32540 for the secondary prev ...... rin-associated gastric ulcers.

@en

P2093

Bridget Rooney

http://www.w3.org/2001/XMLSchema#string

Danielle Duffy

http://www.w3.org/2001/XMLSchema#string

David J Whellan

http://www.w3.org/2001/XMLSchema#string

Suzanne Adams

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 3.0 Unported

P2860

Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials

Clopidogrel and proton pump inhibitors--where do we stand in 2012?

Esomeprazole and aspirin fixed combination for the prevention of cardiovascular events

Evaluation of the benefits and risks of low-dose aspirin in the secondary prevention of cardiovascular and cerebrovascular events

Evaluation of dose-related effects of aspirin on platelet function: results from the Aspirin-Induced Platelet Effect (ASPECT) study

Heart disease and stroke statistics--2014 update: a report from the American Heart Association

Impact of proton pump inhibitor therapy on the efficacy of clopidogrel in the CAPRIE and CREDO trials.

Contemporary patterns of discharge aspirin dosing after acute myocardial infarction in the United States: results from the National Cardiovascular Data Registry (NCDR).

Prescription prevalence and continuing medication use for secondary prevention after myocardial infarction: the reality of care revealed by claims data analysis

P304

1251-1260

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.1586/14779072.2014.967214

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P5008

ScienceSource

P577

2014-10-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

2014-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

266746035

http://www.w3.org/2001/XMLSchema#string

P698

25300316

http://www.w3.org/2001/XMLSchema#string

P921

aspirin

cardiovascular disease

gastric ulcer

phenols

hydrocarbon

preventive health services

P932

4743601

http://www.w3.org/2001/XMLSchema#string